DR. THOMAS B WIEGMANN, MD
Osteopathic Medicine in Kansas City, MO

License number
Missouri 16174
Category
Osteopathic Medicine
Type
Nephrology
Address
Address 2
4801 E Linwood Blvd Va Med Ctr, Kansas City, MO 64128
5535 Canterbury Rd, Shawnee Mission, KS 66205
Phone
(816) 861-4700
(913) 432-2584

Personal information

See more information about THOMAS B WIEGMANN at radaris.com
Name
Address
Phone
Thomas Wiegmann
5535 Canterbury Rd, Shawnee Msn, KS 66205
(913) 961-7604
Thomas B Wiegmann, age 80
5535 Canterbury Rd, Fairway, KS 66205
(913) 432-7855
(913) 432-2584
(913) 384-5427

Professional information

Thomas Wiegmann Photo 1

Director Clinical Research At Platte Valley Medical Center

Location:
Kansas City, Missouri Area
Industry:
Research


Thomas B Wiegmann Photo 2

Dr. Thomas B Wiegmann - MD (Doctor of Medicine)

Hospitals:
4801 E Linwood Blvd, Kansas City 64128
4801 E Linwood Blvd, Kansas City 64128
Education:
Medical Schools
Ludwig Maximiliams University / Medical Faculty


Thomas B Wiegmann Photo 3

Thomas B Wiegmann, West Plains MO

Specialties:
Internal Medicine, Nephrology
Work:
Ozarks Medical Center
3000 Independence Sq, West Plains, MO 65775 VA Med Ctr
4801 E Linwood Blvd, Kansas City, MO 64128
Education:
Ludwig-Maximilians-Universitaet Munchen (1970)


Thomas Wiegmann Photo 4

Method For Regional Anticoagulation During Extracorporeal Dialysis

US Patent:
4500309, Feb 19, 1985
Filed:
May 7, 1982
Appl. No.:
6/375890
Inventors:
Dennis A. Diederich - Overland Park KS
Thomas B. Wiegmann - Fairway KS
Robert V. Pinnick - Overland Park KS
Assignee:
The Kansas University Endowment Association - Lawrence KS
International Classification:
A61M 103
US Classification:
604 5
Abstract:
An improved hemodialysis method (which may optionally include a hemoperfusion step) including regional extracorporeal citrate anticoagulation is disclosed which permits complete elimination of conventional heparin treatment and possible consequent medical complications from heparin use. The method preferably comprises removing blood from a patient at a level of at least about 80 milliliters per minute, infusing citrate anticoagulant into the blood at a level of up to about 10 millimoles of citrate anion per liter of blood, treating the blood (e. g. , by dialysis and hemoperfusion if desired), thereafter infusing a calcium compound into the blood to restore proper calcium ion level and coagulative properties, and returning the blood to the patient. A calcium-free acetate or bicarbonate dialysate is advantageously employed. A charcoal perfusion filter can optionally be used in conjunction with the dialyzer apparatus.